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Cell sheet technology and magnetic based tissue engineering hold the potential to become 
instrumental in developing magnetically responsive living tissues analogues that can be 
potentially used both for modelling and therapeutical purposes. Cell sheet constructions more 
closely recreate physiological niches, through the preservation of contiguous cells and cell-
ECM interactions, which assist the cellular guidance in regenerative processes.  
We herein propose to use magnetically assisted cell sheets (magCSs) constructed with human 
tendon-derived cells (hTDCs) and magnetic nanoparticles to study inflammation activity 
upon magCSs exposure to IL-1β, anticipating its added value for tendon disease modelling.  
Our results show that IL-1β induces an inflammatory profile in magCSs, supporting its in 
vitro use to enlighten inflammation mediated events in tendon cells. Moreover, the response 
of magCSs to IL-1β is modulated by pulsed electromagnetic field (PEMF) stimulation, 
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favoring the expression of anti-inflammatory genes, which seems to be associated to 
MAPK(ERK1/2) pathway. The anti-inflammatory response to PEMF together with the 
immunomodulatory potential of magCSs opens new perspectives for their applicability on 






Cell sheet technology introduces the possibility of providing stable cellular constructs and 
thus enabling the construction of tissue-like assemblies [1]. In fact, cell sheets (CSs) preserve 
structural elements as ion channels, growth factor receptors, and cell surface proteins as well 
as intercellular connections and matrix components, which assist cell sheet usefulness either 
as biomimetic models to address tissue functional aspects or as tissue substitutes. Previous 
studies reported cell sheet potential to stimulate musculoskeletal tissue regeneration [2, 3]. 
Furthermore, mesenchymal stem cell sheets demonstrated a satisfactory integration into 
native tissues accompanied by anti-inflammatory effects improving cartilage repair and 
treatment of osteoarthritis disease[4, 5]. With inflammation increasingly recognized as a 
central component both in healing and in disease progression, a model to study inflammation 
in tendon tissues taking advantage of CSs technology could become an important tool to 
advance knowledge in this field. For instance, it has been reported that adipose tissue derived 
stem cells (ASC) sheets improve matrix remodelling, and modulate the inflammatory phase 
facilitating tendon healing [6].  
Magnetic cell sheets were constructed by magnetic force-based TE (Mag-TE) as firstly 
proposed by Ito A. et al in 2004 [7], and described by our group [2]. Specifically, this 
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methodology uses magnetite nanoparticles and magnetic force to construct magnetic sheets. 
As so, a confluent monolayer of cells is combined with MNPs and cultured under a 
permanent magnet. MagCSs offer the opportunity to study inflammatory cues and cell 
responses through contact-free stimulation of tendon resident cells in a more tissue-like 
environment with intercellular signaling and structural complexity [5, 8]. Also, magnetic cell 
sheets technology has demonstrated promising results in vascular [9, 10], cardiac[11] and 
musculoskeletal [2, 12, 13] tissue engineering strategies, however, very few examples were 
provided in the literature of magnetic cell sheets in therapies for resolving inflammation. Our 
group has previously shown that magCSs exhibited a tendon-like ECM, good mechanoelastic 
properties and responsiveness, suggesting the applicability of these living patches in tendon 
therapies [2]. 
Moreover, magCSs could also enable to insight on pulsed electromagnetic field (PEMF) 
assisted immunomodulatory effects in cell-based therapies for functional tendon tissue 
replacement.  
A controlled pro-inflammatory milieu can be provided to magnetic tendon cell sheets by the 
exogenous supplementation of interleukin-1 (IL-1) to the culture medium. IL-1 is a pro-
inflammatory cytokine released in inflammatory environments [14] and a well described 
marker of chronic inflammation [15, 16]. From previous reports by our group [17, 18] and 
others [19-21] exposure to low frequency (2 to 75Hz) and low strength (1.5 to 82mT) 
magnetic fields, was shown to modulate tendon cell response to inflammation stresses 
influencing the release and expression of cytokines [17, 18]. Other works also showed the 
effectiveness of the combination of magnetic nanoparticles (MNPs) with magnetic field for 
pain control and enhanced functional recovery in the knee diseases and osteoarthritic lesions 
[22]. Moreover, it has been reported by Rahmi et al. [23] that bone marrow-derived 
mesenchymal stem cell sheets labelled with MNPs upregulated anti-inflammatory factors, 
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TGF-2 and IL-10, which increased the potential of magnetic cell sheets for therapeutic 
strategies.  
In this work, we aimed at using magnetic cell sheet technologies to study tendon cell 
responses in inflammatory environments, induced by exposure of the cell sheets to IL-1. We 
propose magCSs as a pathophysiological model of inflammation to more closely study the 
onset of tendon lesions and the inflammatory molecules affecting injured tendons, taking 
advantage of magCSs properties over cell monolayers. Furthermore, as PEMF favors anti-
inflammatory cell responses, we also studied the role of magCSs assisted by a remote PEMF 
in IL-1 induced tendon cells responses. 
 
2. Materials and Methods 
 
2.1. Isolation and culture of human tendon derived cells (hTDCs) 
hTDCs were isolated from surplus healthy tissue samples of patellar tendons, collected from 
adult patients undergoing orthopedic reconstructive surgeries under protocols previously 
established with Hospital da Prelada (Porto, Portugal) and with informed consent of the 
patients. The content of the written informed consent and related procedures were reviewed 
and approved by the Hospital Ethics Committee (P.I. N.º005/2019). The tendon tissue 
identification and quality (healthy/diseased) was assessed by the medical team during 
surgical intervention.  
Following a previously established protocol [24-26], tendon samples were minced using a 
sterile scalpel. PBS drops were added in a continuous basis to keep a moist environment and 
reduce cell damage by mechanical forces. The excess of PBS was removed using a filtration 
system for 50 ml tubes (Falcon). Minced samples were collected into a 50 mL tube (Falcon), 
already containing an enzymatic solution of collagenase (0.1%, Sigma-Aldrich, C6885, USA) 
with 2M CaCl2 (1:1000, VWR, Germany) and 1% bovine serum albumin (BSA) (Sigma-
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Aldrich, USA) for 1h at 37˚C under constant agitation. A ratio of 1:1 of minced tissue to the 
enzymatic solution was considered. After incubation, digested samples were filtered and 
centrifuged three times at 290 g for 5 min, and the supernatant discarded. Isolated hTDCs 
were expanded in α-MEM medium (A-MEM, Invitrogen, Life Technologies Limited, 
Paisley, UK) composed of α-MEM supplemented with 10% fetal bovine serum (FBS) 
(Alfagene, Life Technologies Limited, UK) and 1% antibiotic/antimicotic solution (A/A) 
(Alfagene, Life Technologies Limited, UK) in humidified 5% CO2 atmosphere. hTDCs from 
passage 1 to 3 were used to perform all the experiments. 
 
2.2. Magnetic cell sheets construction, culture, and stimulation 
Magnetic cell sheets (magCSs) were constructed as previously described by our group.[2] 
Briefly, hTDCs were seeded onto 24-well tissue culture plates (BD Biosciences, San Jose 
UK) at a density of 500,000 cells per well. Two hours after seeding, the chitosan coated iron 
oxide MNPs (nanomag-C, 04-00-152, Micromod, Germany) were added to adherent hTDCs 
at 200 pg/cell. Then, MNPs were overnight incubated with the cells in α-MEM medium (A-
MEM, Invitrogen, Life Technologies Limited, Paisley, UK) on a 24-well permanent magnet 
well-array plate (magnetic induction of 350mT per magnet per well) in humidified 5% CO2 
atmosphere.  
Then, 16h after MNPs addition, magCSs were washed with D-PBS (Sigma-Aldrich, Saint 
Louis, MO) and the culture medium replaced by either i) α-MEM medium (magCSs Control 
group) or ii) α-MEM medium supplemented with IL-1β (1 ng/mL, Alfagene, Life 
Technologies Limited, UK) for 24 hours (magCSs IL-1 group) to induce inflammatory cues 
in hTDCs, as previously established [17]. To assess the immunomodulatory effect of PEMF, 
24h after supplementation with IL-1 magCSs were stimulated with PEMF (magCSs IL-1 
PEMF group) using a magnetotherapy device (Magnum XL Pro; Globus Corporation, Italy) 
for 1 hour in humidified 5% CO2 atmosphere. The magCSs were placed between two coils 
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(solenoids) and the magnetic field was generated by the electric current that goes through a 
coil. The stimulus provided was selected from a set of therapeutic programs used in health-
rehab medical treatments.  
These treatments typically range between 10 min and 12 hours and the parameters of 
magnetic fields are between 5 to 200Hz, and strength 0.2 to 10mT. 
These parameters are known to be safe and with therapeutic value in humans. Having this in 
mind, together with the outcomes from previous studies of our group with tendon cell 
cultures, the PEMF parameters of  5 Hz of frequency, 4 mT of intensity and 50 % duty cycle 
were established as optimal parameters for modulating inflammatory cues [17]. Moreover, in 
these studies we also determined the 1h exposure period as suffice to elicit a desirable 
response in IL-1 primed tendon cells either cultured in monolayer (Vinhas, A. et al, 2020a) 
or in magnetic-responsive systems (Vinhas, A. et al, 2020b). 
In sum, the following conditions were investigated: i) magCSs in α-MEM medium (Control), 
ii) IL‐1β‐treated magCSs (IL1-), iii) IL‐1β‐treated magCSs exposed to PEMF (IL1- 
PEMF). Magnetic cell sheets were characterized at day 3 (counting from tendon cell seeding 
on the plates) for cell viability, proliferation and morphological analysis. Matrix deposition, 
collagen production, and gene expression levels of tendon and inflammatory markers were 
also investigated. Additionally, the culture media of magCSs was collected and the presence 
of inflammatory mediators quantified using ELISA assays. 
 
2.3. Cell distribution and matrix deposition - tendon cell monolayers vs magCSs 
constructions  
A Hematoxylin & Eosin (HE) stain was performed for comparative analysis of the 
distribution of cells in tendon cell monolayer and magCSs constructions. Thus, tendon cell 
monolayers and magCSs (control condition), both seeded at 500,000 cells/well and cultured 
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for 3 days were stained using Hematoxylin (7211, Thermo Scientific) and Eosin-Y Alcoholic 
solution (71204, Thermo Scientific) for cytoplasmic detection. 
To confirm the stability of magCSs and matrix deposition in magCSs and in tendon cell 
monolayer, Sirius Red/Fast Green Collagen Staining Kit (9046, Chondrex) was performed for 
a qualitative analysis. magCSs and tendon cell monolayers were fixed with a 10% (v/v) 
neutral buffered formalin solution (Bio Optica, Milano, Italy). Then the dye solution from the 
kit was added to the magCSs and to the cells in monolayer followed by 40 min incubation.  
 HE and Sirius Red/Fast Green stained samples were visualized and images obtained using a 
fluorescence inverted microscope  (Axio Observer, Zeiss, Göttingen, Germany).  
Immunostaining for collagen I was also performed as detailed described in section 2.9.  
 
2.4. Assessment of cellular viability and cell proliferation 
Live/dead assay was performed to assess cellular viability. Briefly, the magCSs were 
incubated for 20 min with calcein‐AM (2 μg/ml) and propidium iodide (3 μg/ml), both from 
Life Technologies Limited, UK. Afterwards, cells were washed with PBS and visualized 
under a fluorescence inverted microscope (Axio Observer, ZEISS, Germany). 
The cell viability of magCSs was evaluated by MTS assay (Cell Titer 96 Aqueous Solution 
Cell Proliferation Assay, Promega). MagCSs were washed in PBS before a 3h incubation in a 
mixture of phenol red free medium supplemented with FBS and MTS solution (5:1 ratio) at 
37 ºC and 5% CO2 atmosphere, protected from light. Then, the supernatant was transferred to 
a new 96-well plate and the absorbance read at 490 nm (Synergy
TM
HT, BIO-TEK 
Instruments, Winooski, Vermont). Triplicates were made of each sample and a blank sample 
(no cells) reading was performed. 
The cell proliferation of magCSs constructions were evaluated by Quant-It PicoGreen 
dsDNA assay Kit (Thermo Fisher Scientific). magCSs from all conditions were washed with 
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PBS, transferred to a microtube with 1ml of sterile ultrapure water and kept at -80ºC until 
analysis. Samples were thawed, sonicated and processed according to the manufacturer’s 
instructions, at an excitation/emission wavelength of 485/528nm (Synergy
TM
HT, BIO-TEK 
Instruments, Winooski, Vermont). Samples and standards were made in triplicate. 
 
2.5. Morphological characterization  
The morphological characterization of the magCSs was analyzed by scanning electron 
microscopy (Auriga Compact, ZEISS, Germany). The elementary composition of magCSs 
was also investigated by Energy dispersive x-ray spectroscopy (EDS) (JSM-6010LV, JEOL, 
Japan) to confirm the presence of iron (Fe) element within magCSs constructions. For this 
purpose, the magCSs were fixed in 10% (v/v) neutral buffered formalin for 1 h at room 
temperature and dehydrated in a series of increasing ethanol solutions (from 30% to 100% 
(v/v)), followed by a 5min immersion in hexamethyldisiloxane (HMSO, Sigma-Aldrich, 
Saint Louis, MO, USA). Subsequently, the samples were air-dried overnight and sputter 
coated with gold (30s at 20mA, Cressington, C5219, Model 108A).  
 
2.6. Gene expression evaluation by RT-PCR  
The expression of tenogenic markers, namely Mohawk (MKX), Scleraxis (SCX), 
Tenomodulin (TNMD), Decorin (DCN), Metalloproteinase-1 (MMP-1), Metalloproteinase-2 
(MMP-2), Metalloproteinase-3 (MMP-3), Inhibitor of Metalloproteinase-1 (TIMP-1), 
Collagen type I (COL1A1), Collagen type III (COL3A1), and inflammation markers, namely 
Interleukin-8 (IL-8), Interleukin-1β (IL-1β), Tumor necrosis factor (TNF), Interleukin-6 (IL-
6), Interleukin-10 (IL-10), Interleukin-4 (IL-4), was assessed by real time RT-PCR. 
Total RNA was extracted from all samples under study, using TRI reagent (T9424, Sigma-
Aldrich, Saint Louis, MO, USA) according to the manufacturer’s instructions. Briefly, TRI 
reagent was added to each sample and stored at -80°C. After defrosting, samples were 
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incubated with chloroform (Sigma-Aldrich, Saint Louis, MO, USA) for 15 min and 
centrifuged at 12,000 g for 15 min at 4°C. The aqueous fraction was collected and 
isopropanol (Sigma-Aldrich, Saint Louis, MO, USA) was added. After 10 min, samples were 
centrifuged at 12,000 g for 10 min at 4°C. RNA pellet was washed with ethanol (70% v/v) 
and subsequently centrifuged at 7,500 g for 5 min at 4°C. RNA quantity and purity were 
determined with a NanoDrop ND-1000 spectrophotometer (Wilmington, DE, USA). The 
cDNA synthesis was performed using the qScript cDNA Synthesis kit (qScript
TM
 cDNA 
Synthesis Kit, Quanta Biosciences, Gaithersburg, MD, USA) in a Mastercycler Realplex 
(Eppendorf, Hamburg, Germany). An initial amount of total RNA of 1 µg in a total volume 
of 20 µL was used per each and every sample. The quantification of the transcripts was 
carried out by quantitative polymerase chain reaction (qPCR) using the PerfeCTA SYBR 
Green FastMix kit (Quanta Biosciences, Gaithersburg, MD, USA) following the 
manufacturer's protocol, in a Real-Time Mastercycler Realplex thermocycler (Eppendorf, 
Hamburg, Germany).  
The primers were pre-designed with PerlPrimer v1.1.21 software (Supplementary Table S1) 
and synthesized by MWG Biotech. GAPDH was used as the housekeeping gene. The 2
-ΔΔCt
 
method was selected to evaluate the relative expression level for each target gene. All values 
were firstly normalized against GAPDH expression values, and then to magCSs cultured in α-
MEM medium at day 3. 
 
2.7. Quantification of secreted forms of inflammatory mediators 
The release of inflammatory mediators was analysed from cell supernatants of all magCSs 
conditions. The supernatants were tested using commercially available enzyme immunoassay 
kits for TNF (Human TNF ELISA Kit, EK0525, Tebu-Bio, Fremont, CA, USA), COX-2 
(Human COX-2 ELISA Kit, KA0323, Abnova, Taiwan), PGE2 (Human Prostaglandin E2 
ELISA Kit, KHL1701, Thermo Fisher Scientific, Molecular Probes, Eugene, USA),  IL-6 
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(Human IL-6 Standard ABTS ELISA Development Kit, 900-K16, Peprotech, Rocky Hill, NJ, 
USA), and IL-10 (Human IL-10 Standard ABTS ELISA Development Kit, 900-K21; 
Peprotech, Rocky Hill, NJ, USA). MAPK protein phosphorylation was also determined in 
cytoplasmic protein extracts using the PhosphoTracer ERK1/2 (pT202/Y204)+p38 MAPK 
(pT180/Y182)+JNK1/2/3 (pT183/Y185) Elisa Kit (Abcam, ab119674, Cambridge, UK). 
Each and every kit were performed following the manufacturers’ instructions. 
2.8. Quantification of extracellular matrix proteins 
The amount of collagen and non-collagenous proteins was determined using a 
semiquantitative assay, namely Sirius Red/Fast Green Collagen Staining Kit (9046, 
Chondrex). For this purpose, samples of all magCSs conditions were fixed with a neutral 
buffered formalin solution and stored at 4 °C until analysis. Then the dye solution from the 
kit was added to the magCSs followed by 40 min incubation. A dye extraction buffer was 
then mixed and the OD values read in a spectrophotometer (Synergy HT, Biotek Instruments) 
at 540 nm and 605 nm. The results of collagen and non-collagenous proteins were normalized 
to dsDNA quantified in section 2.4. 
 
2.9. Evaluation of tenogenic markers in magCSs constructions 
Protein expression of Mohawk, Tenomodulin and Collagen type I was assessed by 
immunocytochemistry for all magCSs conditions in study. magCSs were washed three times 
with PBS, before and after fixation with 10% (v/v) neutral buffered formalin overnight and 
kept in PBS at 4°C until usage. Subsequently, the cells were incubated with 0.025% Triton‐
X100 in PBS solution (Sigma‐Aldrich, Saint Louis, MO) and the blocking step was 
performed using Normal Horse Serum (Ready To Use Vectastain Kit, PK‐7200; Vector, 
California). The magCSs were incubated overnight with anti-MKX (Rabbit anti-human, 
A83377, 1:100, Sigma‐Aldrich, Saint Louis, MO), anti-Tenomodulin (Rabbit anti-human, 
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ab81328, 1:100, Abcam, Cambridge, UK), anti-Collagen type I (Rabbit anti-human, ab34710, 
1:100, Abcam, Cambridge, UK) diluted in antibody diluent with background reducing 
components (Dako, Santa Clara, CA) at 4°C, followed by 1 h incubation at room temperature 
with the secondary antibody (donkey anti‐rabbit Alexa Fluor 488, 1:200; Alfagene, Life 
Technologies Limited, UK). The samples were washed three times with PBS and stained with 
4′,6‐diamidino‐2‐phenyindole, dilactate (DAPI, 5 μg/μl, D9564; Sigma‐Aldrich, Saint Louis, 
MO) for 10 min.  
The immunostained samples were then analyzed by confocal laser scanning microscopy 
(CLSM, TCS SP8, Leica, Wetzlar, Germany). Images were bidirectionally scanned at 400 Hz 
with Argon (488) and UV (405) lasers and acquired using a 63x magnification objective. 
Three independent experiments were investigated for protein detection by 
immunofluorescence. 
 
2.10. Assessment of nuclei elongation ratio  
Nuclei aspect ratio was determined measuring a minimum of 30 nuclei of confocal 
microscopy images obtained in section 2.9. Nuclei were imaged in different regions of 
magCSs samples. All three magCSs conditions were analysed using ImageJ software (version 
1.52d). The ratio was defined by length was divided by the width to obtain the correspondent 
nuclei elongation ratio.  
 
2.11. Western Blotting  
The MAPK protein phosphorylation was also investigated by western blotting assay. magCSs 
were collected in PBS, resuspended, and the supernatant collected to a new microtube upon 
magnetic separation (MPC®-S, Dynal Biotech).  
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The total cell lysates were prepared using RIPA buffer (Sigma‐Aldrich, Saint Louis, MO) 
with protease inhibitor cocktail (Sigma‐Aldrich, Saint Louis, MO) and phosSTOP (ROCHE, 
Switzerland, EU). The samples were centrifuged for 15 min at 21, 952 g at 4°C and the 
supernatants collected. Afterwards, the BCA protein assay kit (Alfagene, Life Technologies 
Limited, UK) was used to assess the protein content of the samples according to the 
manufacturer’s instructions. The protein extracts were resolved in 10% sodium dodecyl 
sulfate‐polyacrylamide gels, followed by semi‐dry transfer to Amersham™ Protran® 
Western blotting membranes (nitrocellulose; Sigma‐Aldrich, Saint Louis, MO). The transfer 
of the proteins to the membrane was performed in a Pierce Power Station (Thermo Fisher 
Scientific, Molecular Probes, Eugene, OR). The membranes were blocked with 5% BSA in 
Tris‐buffered saline with Tween 20 (Sigma‐Aldrich, Saint Louis, MO) (TBS‐T) and 
incubated with rabbit anti‐phospho‐p44/42 MAPK (Erk1/2) (1:1000) (9102; Cell signaling 
Technology, Danvers, MA), anti-collagen III (1:1000) (ab184993; Abcam, UK), anti-
Tenomodulin (1:1000) (ab184993; Abcam, UK), anti-MKX (1:1000) (HPA006927; Sigma‐
Aldrich, Saint Louis, MO) and anti‐α smooth muscle actin (1:2000) (ab32575; Abcam, UK) 
antibodies for 1h at room temperature under mild agitation. The membranes were washed 
three times with TBS‐T and then incubated with a secondary antibody (1:2000) (Anti‐Rabbit 
IgG Alkaline Phosphatase antibody, A9919, Sigma‐Aldrich, Saint Louis, MO) for 1h at RT. 
A colorimetric AP substrate reagent kit (1706432; BioRad, Hercules CA) was used for color 
development. Semi-quantitative analysis was performed for pMAPK bands using ImageJ 
software (version 1.52d). α-actin was used as an internal control and for normalization of 
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2.12. Statistical analysis 
Results are expressed as mean  standard error of the mean (SEM). The statistical analysis 
was performed using GraphPad Prism6 software. Data was obtained from 3-independent 
experiments (n=3) analyzed in triplicate, and evaluated by Two-way ANOVA followed by 
Bonferroni post-hoc test for multiple comparison tests.  







3.1. Improved tendon cell organization and matrix production in magCSs constructions  
HE stain was performed to infer on the cellular distribution of magCSs in comparison to a 
simple tendon cell monolayer. A hyperdense culture was observed in both cultures (Fig. 1A, 
1B) however cells in tendon cell monolayer are more randomly distributed. Also, magCSs 
evidence a higher level of spatial organization.  
Sirius red/Fast green staining together with collagen I confirmed matrix deposition by tendon 





3.2. Assessment of viability, cell content and micro-morphology in magCSs constructs  
The MTS and Live/Dead assays were performed to confirm the non-cytotoxic effect of MNPs 
on tendon cells. High cell viability outcomes were verified in all conditions studied 
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demonstrating the suitability of the MNPs concentration applied and of magCSs 
constructions for in vitro cell based approaches (Fig. 2Ai, 2Aii).  
In terms of dsDNA content (Fig. 2Aiii), IL-1β-magCSs under PEMF showed the higher 
dsDNA concentration among all conditions studied (p<0.05).  
In tendon tissues cell nuclei and overall cell morphology follows an elongated shape. 
Elongated nuclei display ratio superior to 1, and, the average aspect nuclei ratio in IL-1β-
magCSs under PEMF showed the highest values (>1) among the conditions studied (Fig. 
2Aiv) (p<0.0001 in comparison to control group and p<0.0001 to IL-1β-magCSs). Moreover, 
IL-1β-magCSs showed the lowest nuclei aspect ratio (p<0.05 to control group and p<0.0001 
to IL-1β-magCSs under PEMF). This result suggests that PEMF favors an elongated shape 
nucleus, and that IL-1β rich environments influence a more rounded shaped nucleus. 
SEM analysis (Fig. 2B) also supports a tendency for the alignment distribution of magCSs 
within different layers of cells suggesting the establishment of intercellular connections 
among cells.  
 
3.3. Tenogenic phenotype in magCSs under an IL-1β rich environment  
The impact of IL-1β supplementation and PEMF exposure was evaluated on the tendon 
markers expressed by magCSs to assess their influence on the maintenance of tenogenic 
profile. With an exception for SCX, the relative expression of MKX, TNMD, and DCN were 
significantly affected by the IL-1β treatment [19, 27, 28] (Fig. 3).  
MKX and DCN show a significant decrease in the expression values in comparison to Control 
and IL-1β PEMF groups (p<0.05) (Fig. 3A), while TNMD levels tend to decrease with both 
PEMF stimulation (p<0.01 to Control) and IL-1β treatment (p<0.0001 to Control group) (Fig. 
3A). SCX expression seems not to be affected by IL-1β treatment or PEMF, showing similar 
values for all conditions studied (Fig. 3A). The maintenance of SCX expression levels has 
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been also observed in our previous works [27]. Overall, IL-1β treatment combined with 
PEMF stimulation leads to an increment in tendon gene expression up to the levels of non-IL-
1β magCSs (Control group). 
The presence of the tenogenic proteins MKX and TNMD were also investigated. MKX and 
TNMD were observed in all conditions (Fig. 3B), however the signal intensity of MKX was 
lower in magCSs treated with IL-1β. Additionally, the presence of these proteins together 
with collagen III was confirmed by western blot analysis (Fig. 4Bii).   
 
3.3. Tendon-like ECM matrix in magCSs  
The normal function of tissues depends on the maintenance of the unique extracellular matrix 
(ECM) composition and architectural arrangements. In the particular case of tendon tissues, 
the matrix organization is critical to provide structure and biomechanical properties. Since we 
supplemented magCSs with a powerful inflammatory mediator that could contribute for 
architectural changes in ECM, we assessed the expression of enzymes associated to collagen 
degradation and to ECM remodeling phenomena.  
As expected, the expression of MMP-1, MMP-2 and MMP-3 increased with IL-1β treatment 
in comparison to control group (MMP-1, p<0.01; MMP-2, MMP-3 p<0.0001) and to magCSs 
exposed to PEMF (MMP-1, p<0.05; MMP-2, MMP-3, p<0.0001) (Fig. 4Ai) [17, 27]. 
Interestingly MMP-1 and MMP-3 levels in IL-1β-magCSs stimulated with PEMF are higher 
than in control group (MMP-1, p<0.01; MMP-3, P<0.0001). Also, the expression of TIMP-1 
is upregulated in magCSs stimulated with PEMF (p<0.0001), while in IL-1β-magCSs was 
downregulated (p<0.0001, in comparison to non-PEMF IL-1β-magCSs) (Fig. 4Aii). It has 
been reported that increased levels of MMPs and low levels of TIMP-1 are associated to the 
degenerative changes in chronic tendinopathy [29]. In inflammatory conditions, elevated 
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MMPs and decreased expression of inhibitors result in the degradation of collagens, 
proteoglycans and elastin fibers in the ECM [30].  
In sum, the IL-1β-magCSs respond to IL-1β supplementation at the gene expression level. 
PEMF seems to stimulate positively the expression of MKX, TNMD, DCN and TIMP-1, and 
inhibit MMP-1, MMP-2 and MMP-3 in IL-1β-magCSs. 
Collagen type I is the major protein in connective tissues and an increase in collagen type III 
has been related both to remodeling phase of healing and to fibrotic tissues [31]. We further 
investigated how IL-1β treatment could directly affect the degradation of collagen and other 
proteins in ECM produced by magCSs. The expression of collagen type I (COL1A1) was 
decreased in IL-1β-magCSs (p<0.0001 in comparison to control group) but collagen type III 
(COL3A1) remained unchanged (p>0.05) (Fig. 4Aiii).  
However, in terms of collagen production, no significant differences were found between 
control and IL-1β-magCSs groups (p>0.05). Nevertheless, the production of non-collagenous 
proteins was deeply reduced in IL-1β-magCSs (p<0.0001 in comparison to Control group and 
to IL-1β-magCSs stimulated with PEMF group) (Fig. 4Bi).  
When PEMF is applied on IL-1β-magCSs, there is an increment in the COL3A1 expression 
(p<0.001) and in the amount of both collagenous (p<0.0001) and non-collagenous (p<0.0001) 
proteins. The increment is also significant in comparison to magCSs Control group 
(p<0.0001) (Fig. 4Bi), suggesting an anabolic role of PEMF in magCSs treated with IL-1β on 
the quality and quantity of the ECM.  
Thus, PEMF seems to significantly influence the production of collagen (p<0.05) in IL-1β-
magCSs. The fact that collagen synthesis is also increased in comparison to control (p<0.05) 
group suggests that PEMF promotes the deposition of a collagen rich-ECM matrix. 
Furthermore, the increased levels of COL3A1 also supports that the synthesis and deposition 
of collagen type I and collagen type III, necessary for the remodeling process [32].   




3.4. Investigation of cytokine profile in magCSs   
In an inflammatory milieu, cells communicate through networks of inflammatory mediators 
to inform about extracellular conditions and adjust the response accordingly. The treatment of 
magCSs with IL-1β was aimed to study tendon cell responses to such cues in a cellular 
matrix enabling juxtacrine and paracrine signaling. Pro-inflammatory genes IL-8, IL-1β, 
TNF, and IL-6 showed increased expression in IL-1β-magCSs, when compared with the 
other groups under study (p<0.05) (Fig. 5Ai). Furthermore, the transcript levels of anti-
inflammatory factors IL-10 and IL-4 were decreased in IL-1β-magCSs, in comparison to 
control (IL-10, p<0.05; IL-4, p<0.01) and to PEMF stimulated (IL-10, p<0.0001; IL-4, 
p<0.0001) conditions (Fig. 5Bi).  
These results are supported by ELISA assays, which showed higher concentrations of TNF 
and IL-6 but lower amounts of IL-10 released by IL-1β-magCSs (TNF, p<0.05; IL-6, 
p<0.0001 in comparison to Control group). The effect of PEMF on the inflammatory profile 
of IL-1β-magCSs was also investigated (Fig. 5B). PEMF stimulation caused a decrease in the 
genetic expression of pro-inflammatory cytokines and an increase in the expression of anti-
inflammatory associated genes (IL-8, p<0.001; IL-1β, p<0.05; TNF, p<0.001; IL-6, 
p<0.0001 in comparison to IL-1β-magCSs). Interestingly, the TNF showed levels of 
expression even lower than the Control group (p<0.05), while the expression of both IL-4 and 
IL-10 was approximately 3-fold higher (p<0.05) (Fig. 5Bi). The dissimilar values between 
PEMF and Control groups may be associated to the anti-inflammatory effect of PEMF, even 
in the absence of IL-1β treatment. 
Correlating with the results obtained for gene expression, the release into the culture medium 
of TNF and IL-6 were significantly reduced under PEMF in comparison to IL-1β-magCSs 
(p<0.0001) and to the Control group (p<0.01) (Fig. 5Aii). The concentration of PGE2, a lipid 
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mediator of pain and acute inflammation, also followed this trend (IL-1β-magCSs, p<0.001; 
magCSs Control, p<0.05) (Fig. 5Aii). 
Additionally, the release of IL-10, was significantly increased with PEMF in comparison to 
the other conditions (Control group, p<0.01; IL-1β-magCSs, p<0.0001) (Fig. 5Bii). As 
expected, tendon cells in magCSs constructions respond to IL-1β treatment with pronounced 
pro-inflammatory cues. Moreover, the pro-inflammatory signals can be modulated by 
exposure to PEMF, as observed in IL-1β-magCSs, in which the expression levels of pro-
inflammatory cues were lower than the ones shown for other conditions. According to these 
outcomes, PEMF seems to effectively reestablish the levels of anti-inflammatory factors in 
inflammatory conditions, necessary to the resolution of inflammation to continue healing.  
 
3.5. Involvement of MAPK signaling pathway in the regulation of inflammation cues 
 
In the complex inflammation process, different signaling pathways may be involved and may 
contribute to the activation and production of multiple pro-inflammatory molecules, namely 
IL-1β, TNF or IL-6 [32-34].  The p38 mitogen associated protein kinase MAPK(ER1/2) 
pathway is involved in many tissues responses, including tendons tissues. [35-37]. In this 
sense, and considering the gene and protein response of magCSs to IL-1β treatment 
concomitantly modulated by PEMF stimulation, we investigated the potential of 
MAPK/ERK1/2 on magCSs regulation (Fig. 6). The MAPK(ER1/2) activation is a 
consequence of different cytokine stimuli, including IL-1β, triggering the expression of pro-
inflammatory factors, such as COX-2 and PGE2 [38].  
The results of phospho-MAPK(ERK1/2) were assessed by western blot (Fig. 6Ai). Although 
the bands do not show evident differences, the quantification of the bands intensity indicates 
that PEMF reduces phospho-MAPK(ERK1/2) in magCSs. Phosphorylated ERK1/2 was 
further assessed by ELISA assays and follow the trend of the cytokine profile, with an 
increased concentration in IL-1β-magCSs (Control group, p<0.05) (Fig. 6Aii). Again, PEMF 
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stimulated IL-1β-magCSs show lower values in comparison to control group (p<0.001) (Fig. 
6Ai).  These results can suggest a possible role and targeted action of PEMF in 
MAPK(ERK1/2) activation in an IL-1β induced pro-inflammatory response.  
The pro-inflammatory factors, COX-2 and PGE2, have been widely described as products 
resultant from MAPK pathway activation [37-39] (Fig. 6B). In this study, both COX-2 
transcripts and protein expression were increased with IL-1β treatment (p<0.05), and 
decreased with PEMF stimulation (p<0.05) (Fig. 6Bi).  
The release of PGE2 demonstrates a similar tendency (Fig. 6Bii). Interestingly, under PEMF 
the amounts of released PGE2 are lower than the ones of Control group (p<0.05). 
 
4. Discussion 
-      Establishment of an in vitro model with magCSs 
 
The prolonged exposure to pro-inflammatory mediators is known to lead to chronic 
inflammation [40], and ultimately to tendon disorders. Exposing magnetic tendon cell sheets 
to an inflammatory cytokine-rich milieu, we expected to more accurately predict tendon cell 
behavior in vivo and the potential immunomodulatory contributions of magCSs for tendon 
therapies.  
To antagonize such influence and improve scaffold-free strategies, we also explored the 
immunomodulatory effect of PEMF on magCSs conditioned to IL-1.  
The inflammatory stimulus provided by IL-1 influenced the tenogenic phenotype reducing 
the relative gene expression of MKX, TNMD, and DCN. Conversely, pro-inflammatory genes 
were increased, supported by the increment of pro-inflammatory mediators secreted by IL-
1-magCSs. These outcomes, together with the decrease in anti-inflammatory genes and 
soluble factors, IL-4 and IL-10, suggest that magCSs respond to IL-1 by increasing the 
expression and production of inflammatory factors into the environment[41, 42]. This 
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response also resulted in a decrease in COL1A1 expression and in the synthesis of ECM 
proteins (non-collagenous) suggesting that inflammatory stimuli may also interfere with the 
quality of the ECM. The matrix composition, organization and cell-matrix interactions are 
important for normal function of tendon. However, during tendinopathy conditions the 
normal composition of ECM suffers alterations and has been suggested to be the major factor 
for the development of this disorder [32]. These alterations interfere with the inflammatory 
cell signaling and with the cytokine release, thus affecting the important mechanisms of 
repair [43]. These mediators are responsible for ECM disorganization, which was recognized 
as a major cause for tendon injuries. In tendinopathy conditions, matrix degradation and the 
collagen content becomes more heterogeneous and disordered [31, 44]. The degradation of 
collagen is normally regulated by MMPs and by the activity of their inhibitors (TIMPs). 
Miller et al.[45] reported that pro-inflammatory factors as TNF and IL-1 stimulate 
catabolic degradation of collagen matrix via MMP-2 in intervertebral disc cells under normal 
and inflammatory environments, stimulated by IL-1.  
To elucidate on the mechanisms associated to the IL-1 treatment, we investigated a possible 
involvement of the intracellular signaling pathway, MAPK(ERK1/2), which is activated by 
stressful and pro-inflammatory stimuli.  
Our results indicated that IL-1 treatment leads to the activation of MAPK(ERK1/2), likely 
due to the increment in IL-1 expression on magCSs. In addition, results demonstrated higher 
expressions of COX-2 and PGE2 by the IL-1-magCSs. COX-2 is responsible for the high 
levels of prostaglandins, such as PGE2 present in acute and chronic inflammation. MAPK 
(ERK1/2) signaling is involved in COX-2 expression and the inhibition of this pathway 
causes a reduced COX-2 expression [46]. Moreover, several studies focusing on 
inflammation reported that IL-1 influences the levels of COX-2 and PGE2 through the 
activation of the MAPK(ERK1/2)  pathway [39, 43-45, 47].  




- Contributions of PEMF stimulation to resolve inflammatory cues in IL-1β-
magCSs 
 
From our previous studies, PEMF has shown a great impact in the inflammatory profile of 
IL-1β-hTDCs influencing the release and expression of cytokines [17, 18, 39].  Despite the 
fact that such works were performed in monolayer cultures and in the absence of MNPs, the 
combination of MNPs actuated by an external magnetic field could stimulates specific 
biochemical responses [48]. The response of MNPs to magnetic fields can provide additional 
signals that cells respond to, likely creating synergistic actions to guide the healing process 
[2]. For instance, the combination of MNPs and scaffolds with magnetic fields and stem cells 
has shown to increase the osteogenic differentiation, angiogenesis and bone regeneration 
[49]. Moreover, cell internalized MNPs can be visualized by conventional imaging 
techniques (e.g. MRI, CT), enabling visualization in preclinical and clinical approaches. 
We investigated a possible influence of MNPs and PEMF on cell organization and 
distribution within magCSs. The results showed a tendency for parallel alignment of tendon 
cells, within magCSs constructions. The cellular organization is an important point to obtain 
proper healing and disorganized architectures may favor degenerative conditions mediated by 
pro-inflammatory niches [44].  
In relation to gene expression level, magnetic stimulation in inflamed environment provoked 
a pronounced increase in MKX, TNMD and DCN. Herein, the expression of genes encoding 
for matrix degrading enzymes were downregulated after the exposure to PEMF, and 
upregulated for the TIMP-1 in comparison to the Control group. 
Moreover, the expression of collagens increased in IL-1β-magCSs under PEMF stimulation 
and consequently the production of collagen proteins. During the healing process, high 
production of collagen fibers is essential, where collagen type III is required for the assemble 
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of collagen type I fibers. Thus, an increase in collagen type III may suggest cellular guidance 
towards healing [31].  
Our results demonstrate that PEMF supports the production of a tendon-like matrix, promote 
collagen synthesis, and a decrease in MMPs gene expression, evidencing a regulatory 
influence of PEMF in tendon healing process. Understanding the mechanisms associated to 
the expression of inflammatory mediators may provide molecular tools for improving current 
therapeutics [50]. The effect of PEMF in MAPK(ERK1/2) activation of IL-1-magCSs and 
the consequent synthesis of COX-2 and PGE2,was investigated in this work. Several studies 
have reported that PEMF can modulate the activation of intracellular signaling associated to 
inflammatory profiles mediated by NF-Kb, mTOR or MAPK pathways [17, 51]. 
Additionally, the phosphorylation of p38 MAPK(ERK1/2) was shown to be inhibited by the 
exposure to PEMF (1.5mT; 75Hz, 10% duty cycle) in an inflammatory model of synovitis, 
leading to the decrease of TNF [52]. 
In our study, we demonstrate not only a reduction on the phosphorylation of MAPK(ERK1/2) 
in IL-1-magCSs but also reduced levels of COX-2 and PGE2. An exposure to a PEMF (1.5 
mT, 75 Hz, 1/10 duty cycle) was also shown to reduce the release of PGE2 as well as of IL-6 
and IL-8 from bovine synovial fibroblasts from osteoarthritis patients treated with IL-1β [53]. 
Thus, the reduction on the phosphorylation of MAPK(ERK1/2) could also indicate that 
PEMF may influence the expression and synthesis of pro-inflammatory cytokines and lipid 
mediators COX-2 and PGE2 in magCSs through MAPK(ERK1/2). These outcomes are in 
accordance with published studies[51] supporting the application of magnetic fields in 
pathologies with an inflammatory context.  
Overall, these results show the applicability of magCSs as a cellular model for tendon studies. 
Moreover, PEMF shows a relevant influence over inflammatory mediators and in the quality 
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and quantity of ECM in magCSs that goes beyond the expression of cytokines, and may 




This work shows that magCSs technologies offer new possibilities as advanced cell culture 
models for tendon tissue engineering, including pathophysiological models of inflammation 
to assist the understanding of the onset and progression of tendon disorders. In accordance to 
previous studies, PEMF evidences a modulatory action in the inflammatory profile of IL-1 
primed tendon cells in magCSs constructions, via MAPK(ERK1/2) pathway. The remote 
control over magCSs strengthens the role of PEMF in tendon therapies, and highlights the 
promise of magCSs as a living patch to overcome sustained inflammatory events and to drive 
tendon repair and regeneration. 
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niches. In this work, we aimed to apply magCSs technologies to study hTDCs responses in 
inflammatory environments. Overall results show that PEMF-stimulated-magCSs hold 
evidence for immunomodulatory properties and to become a living tendon model envisioning 
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Figure Captions   
 
 
Figure 1: Characterization of tendon cells in monolayers (A) and in magnetic cell sheets 
construction (magCSs) (B) after 3 days in culture. Cellular distribution assessed by HE 
staining (Ai, Bi) of the tendon cells monolayer and magCSs (scale bar 2000m). Matrix 
deposition (Aii, Bii) assessed by Sirius red/Fast green collagen staining and immunolocation 
of Collagen I (COL I) (green). Nuclei were counterstained with DAPI (blue) (x63, scale bar 
50m). Insets are representative images in lower amplification (x20, scale bar 100m).  
 
Figure 2: Viability, proliferation and morphology of tendon cells in magnetic cell sheets 
(magCSs) after 3 days in culture. Ai) Cell viability was determined by MTS assay. Aii) 
Live and dead staining for viable (green) and dead (red) cells (x20, scale bar 50m, merged 
images). Aiii) Cell content determined by the PicoGreen assay. Aiv) Nuclei elongation ratio. 
W defines nuclei width whereas L defines nuclei lenght . Symbols denote statistical 
differences * for p<0.05; ** for p<0.01 and **** for p<0.0001. B) SEM micrographs analysis 
(x500, 50m). Insets are representative images of magCSs in lower amplification (x150, 
100m). The graphs and the tables represent the atomic percentage (wt %) of carbon (C), 
oxygen (O) and iron (Fe) detected in the magCSs of the different experimental groups. Two 
different samples per condition were considered. The “IL-1” condition refers to magCSs 
treated with IL-1 while “IL-1 PEMF” defines magCSs treated with IL-1 exposed to 
PEMF. Control group refers to magCSs in the absence of IL-1 and PEMF.  
 
Figure 3: Assessment of the genetic expression and immune-location of tenogenic 
markers in magnetic cell sheets (magCSs) after 3 days in culture. A) Relative gene 
expression of Mohawk (MKX), Scleraxis (SCX), Tenomodulin (TNMD), Decorin (DCN) by 
real time RT-PCR. Expression of target genes was normalized against GAPDH housekeeping 
gene. Symbols denote statistical differences, * for p<0.05; ** for p<0.01 and **** for 
p<0.0001. B) Immunolocation of the tenogenic markers (green), Mohawk and Tenomodulin 
assessed at day 3 (x63, scale bar 50 m). Nuclei were counterstained with DAPI (blue). The 
“IL-1” condition refers to magCSs treated with IL-1 while “IL-1 PEMF” defines magCSs 
treated with IL-1 exposed to PEMF. Control group refers to magCSs in the absence of IL-1 
and PEMF.  
 
Figure 4: Extracellular matrix in magnetic cell sheets (magCSs) after 3 days in culture. 
Ai) Relative gene expression of metalloproteinases (MMPs); metalloproteinases-1, -2, -3 
(MMP-1, MMP-2, MMP-3), Aii) tissue inhibitor metalloproteinase-1 (TIMP-1) and Aiii) 
collagen type I (COL1A1) and collagen type III (COL3A1) by real time RT-PCR. Bi) 
Quantification of collagen and non-collagenous proteins by Sirius Red/Fast Green Collagen 
staining kit. Bii) Western blot of collagen III (COL III), tenomodulin (TNMD) and mohawk 
(MKX). Protein lysates were analyzed by probing for COL III, TNMD, MKX and α-smooth 
muscle actin (control) (two experimental replicates from two biological replicates). Symbols 
denote statistical differences * for p<0.05; ** for p<0.01; *** for p<0.001 and **** for 
p<0.0001. Expression of target genes was normalized against GAPDH housekeeping gene. 
The “IL-1” condition refers to magCSs treated with IL-1 while “IL-1 PEMF” defines 
magCSs treated with IL-1 exposed to PEMF. Control group refers to magCSs in the absence 
of IL-1 and PEMF.  
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Figure 5: Determination of gene expression and release of pro- and anti-inflammatory 
factors in magnetic cell sheets (magCSs) after 3 days in culture. Ai) Gene expression of 
pro-inflammatory genes (IL-8, IL-1, TNF and IL-6) and Bi) anti-inflammatory genes 
(IL-10 and IL-4) by real time RT-PCR analysis. Expression of target genes was normalized 
against GAPDH housekeeping gene. Aii, Bii) Release of TNF, IL-6, PGE2 and IL-10 
quantified in cultured medium by ELISA assays. Symbols denote statistical differences * for 
p<0.05; ** for p<0.01; *** for p<0.001 and **** for p<0.0001. The “IL-1” condition refers 
to magCSs treated with IL-1 while “IL-1 PEMF” defines magCSs treated with IL-1 
exposed to PEMF. Control group refers to magCSs in the absence of IL-1 and PEMF. 
 
Figure 6: phosphorylated MAPK(ERK1/2) in magnetic cell sheets (magCSs) after 3 
days in culture. Ai) Western blot of phosphorylated MAPK (pMAPK (Erk1/2). Bands 
intensity were quantified to α-smooth muscle actin (control) (two experimental replicates 
from two biological replicates) and Aii) Quantification of ERK1/2 (pT202/Y204) by ELISA 
assay Bi) Relative expression of COX-2, and Bii) Quantification of COX-2 release in cultured 
medium. Expression of target genes was normalized against GAPDH housekeeping gene. 
Symbols denote statistical differences * for p<0.05; ** for p<0.01; *** for p<0.001 and **** 
for p<0.0001. The “IL-1” condition refers to magCSs treated with IL-1 while “IL-1 
PEMF” defines magCSs treated with IL-1 exposed to PEMF. Control group refers to 

























































         
